Put Skin Cancer Risk With Hydrochlorothiazide in Perspective

October 2020

Patients will ask you if they should stop hydrochlorothiazide...based on new labeling that points out increased skin cancer risk.

Growing evidence suggests a link between hydrochlorothiazide and nonmelanoma skin cancer...mostly squamous cell carcinoma.

Photosensitivity with hydrochlorothiazide may play a role.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote